Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
The trial found no significant difference in hospitalization or death risk between patients using long-term oxygen therapy for 24 hours versus 15 hours per day, potentially offering more freedom for those with severe hypoxemia.
Family Medicine/General Practice September 26th 2024
Adjuvant durvalumab therapy led to a median overall survival of 55.9 months compared to 33.4 months with placebo in patients with limited-stage small-cell lung cancer who did not progress after chemoradiotherapy.
Oncology, Medical September 24th 2024
Cannonball pulmonary lesions on imaging should prompt a thorough investigation for underlying malignancy, particularly germ cell tumors.
Internal Medicine September 11th 2024
Epoch Health
The FDA’s approval of new COVID-19 vaccines targeting the KP.2 strain comes amidst concerns about waning immunity and evolving virus variants.
Family Medicine/General Practice September 4th 2024
The CDC reports “very high” COVID-19 levels in 32 states, with two new Omicron variants accounting for more than half of all US cases.
Family Medicine/General Practice September 3rd 2024
Recent studies have identified a range of chemical compounds released by face masks, including microplastics, volatile organic compounds, and plasticizers, prompting a closer examination of potential cumulative exposure risks.
Allergy & Immunology August 29th 2024